International Conference highlight global networking, scientific advancements, and professional development at this year's meeting.

Patients with COPD and type 2 inflammation receiving mepolizumab vs. placebo had decreased moderate and severe exacerbation ...

Pulmonary embolism (PE) is more common in children than previously thought, according to a study presented at the American ...

The FDA granted approval to mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant ...

STOCKHOLM, SE / ACCESS Newswire / May 22, 2025 / Vicore Pharma Holding (STO:VICO) - Stockholm, May 22, 2025 - Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, ...

New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of ...

HealthDay News — For nurses in critical care areas, adding a team therapist can reduce burnout and improve resilience, according to a study presented at the American Thoracic Society 2025 ...

As-needed albuterol-budesonide yields a lower risk for severe asthma exacerbation among patients with mild asthma, according ...

Patients with pulmonary embolism (PE) who were treated with mechanical thrombectomy (MT) within 12 hours of hospital ...